A Assembleia Legislativa decreta, nos termos da alínea 1) do artigo 71.º da Lei Básica da Região Administrativa Especial de Macau, para valer como lei, o seguinte:
1. São aditadas, respectivamente, às tabelas I-A, II-A, II-B e II-C, a que se refere o n.º 2 do artigo 4.º da Lei n.º 17/2009, alterada pelas Leis n.º 4/2014, n.º 10/2016, n.º 10/2019, n.º 22/2020 e n.º 10/2021, as seguintes substâncias constantes do Anexo I à presente lei, da qual faz parte integrante:
1) À tabela I-A as substâncias:
(1) Oripavina;
(2) Orthofluorofentanyl;
(3) Isotonitazene;
(4) Brorphine;
(5) Metonitazene;
2) À tabela II-A as substâncias:
(1) 3-Methoxyphencyclidine;
(2) Diphenidine;
3) À tabela II-B as substâncias:
(1) CUMYL-PEGACLON;
(2) MDMB-4en-PINACA;
4) À tabela II-C a substância 2-Fluorodeschloroketamine, 2-FDCK.
2. São aditadas à tabela IV, a que se refere o n.º 4 do artigo 4.º da Lei n.º 17/2009, as três substâncias Clonazolam, Diclazepam e Flubromazolam, constantes do Anexo I à presente lei, da qual faz parte integrante.
3. São aditadas à tabela V, a que se refere o n.º 5 do artigo 4.º da Lei n.º 17/2009, as três substâncias 4-AP, 1-boc-4-AP e Norfentanyl, constantes do Anexo I à presente lei, da qual faz parte integrante.
A expressão «阿片疊» na versão chinesa da Lei n.º 17/2009 é alterada para «阿片劑».
1. O mapa da quantidade de referência de uso diário a que se refere o n.º 2 do artigo 11.º da Lei n.º 17/2009 é substituído pelo mapa da quantidade de referência de uso diário constante do Anexo II à presente lei, da qual faz parte integrante.
2. As tabelas I a VI a que se refere o artigo 4.º da Lei n.º 17/2009 são substituídas, respectivamente, pelas tabelas I a VI constantes do Anexo III à presente lei, da qual faz parte integrante.
A presente lei entra em vigor no dia seguinte ao da sua publicação.
Aprovada em 7 de Novembro de 2023.
O Presidente da Assembleia Legislativa, Kou Hoi In.
Assinada em 9 de Novembro de 2023.
Publique-se.
O Chefe do Executivo, Ho Iat Seng.
ANEXO I
(a que se refere a alínea 1) do n.º 1 do artigo 1.º)
Tabela I-A |
|||
N.º |
Denominação em chinês |
Denominação em português |
Denominação / Composição química |
133 |
奧列巴文 |
Oripavina |
3-O-demethylthebaine |
134 |
鄰氟芬太尼 |
Orthofluorofentanyl |
N-(2-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide |
135 |
異硝氮烯 |
Isotonitazene |
N,N-diethyl-2-[2-(4-isopropoxybenzyl)-5-nitro--1H-benzo[d]imidazol-1-yl]ethan-1-amine |
136 |
溴啡 |
Brorphine |
1-{1-[1-(4-bromophenyl)ethyl]-piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one |
137 |
甲硝苯 |
Metonitazene |
N,N-diethyl-2-[2-(4-methoxybenzyl)-5-nitro-1H--benzo[d]imidazol-1-yl]ethan-1-amine |
(a que se refere a alínea 2) do n.º 1 do artigo 1.º)
Tabela II-A |
|||
N.º |
Denominação em chinês |
Denominação em português |
Denominação / Composição química |
43 |
3-甲氧基苯環利定 |
3-Methoxyphencyclidine |
1-[1-(3-methoxyphenyl)cyclohexyl]piperidine |
44 |
二苯基乙基哌啶 |
Diphenidine |
1-(1,2-diphenylethyl)piperidine |
(a que se refere a alínea 3) do n.º 1 do artigo 1.º)
Tabela II-B |
|||
N.º |
Denominação em chinês |
Denominação em português |
Denominação / Composição química |
39 |
CUMYL-PEGACLON |
CUMYL-PEGACLON |
5-pentyl-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one |
40 |
MDMB-4en-PINACA |
MDMB-4en-PINACA |
methyl 3,3-dimethyl-2-[1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido]butanoate |
(a que se refere a alínea 4) do n.º 1 do artigo 1.º)
Tabela II-C |
|||
N.º |
Denominação em chinês |
Denominação em português |
Denominação / Composição química |
14 |
氟胺酮 |
2-Fluorodeschloroketamine, |
2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one |
(a que se refere o n.º 2 do artigo 1.º)
Tabela IV |
|||
N.º |
Denominação em chinês |
Denominação em português |
Denominação / Composição química |
65 |
氯氮唑侖 |
Clonazolam |
6-(2-chlorophenyl)-1-methyl-8-nitro-4H- -benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine |
66 |
二氯西泮 |
Diclazepam |
7-chloro-5-(2-chlorophenyl)-1-methyl-1,3--dihydro-2H-benzo[e][1,4]diazepin-2-one |
67 |
氟溴唑侖 |
Flubromazolam |
8-bromo-6-(2-fluorophenyl)-1-methyl-4H--benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine |
(a que se refere o n.º 3 do artigo 1.º)
Tabela V |
|||
N.º |
Denominação em chinês |
Denominação em português |
Denominação / Composição química |
23 |
4-AP |
4-AP |
4-piperidinamine, N-phenyl- |
24 |
1-boc-4-AP |
1-boc-4-AP |
4-(phenylamino)-1-piperidinecarboxylic acid, 1,1-dimethylethyl ester |
25 |
去甲芬太尼 |
Norfentanyl |
propanamide, N-phenyl-N-4-piperidinyl- |
ANEXO II
(a que se refere o n.º 1 do artigo 3.º)
Mapa da quantidade de referência de uso diário
N.º |
Plantas, substâncias ou preparados compreendidos nas tabelas I a IV de consumo mais frequente |
Tabela |
Quantidade de referência de uso diário【com notas】 |
1 |
Heroína |
I-A |
0,25g【Notas 1 e 2】 |
2 |
Metadona |
I-A |
0,1g【Nota 2】 |
3 |
Morfina |
I-A |
0,2g |
4 |
Ópio (o suco coagulado da papoila de ópio) |
I-A |
1g【Nota 3-(2)】 |
5 |
Cocaína (cloridrato) |
I-B |
0,2g【Notas 2 e 4】 |
6 |
Cocaína (éster metílico de benzoilecgonina) |
I-B |
0,03g【Notas 2 e 4】 |
7 |
Canabis (folhas ou sumidades floridas ou frutificadas) |
I-C |
1g【Nota 1】 |
8 |
Canabis (resina) |
I-C |
0,5g【Notas 3-(3) e (4)】 |
9 |
Canabis (óleo) |
I-C |
0,25g【Nota 3-(5)】 |
10 |
Fenciclidina (PCP) |
II-A |
0,01g【Nota 3-(1)】 |
11 |
(+)-Lisergida (LSD) |
II-A |
0,0002g【Nota 1】 |
12 |
MDMA |
II-A |
0,15g【Notas 3-(1) e (6)】 |
13 |
Anfetamina |
II-B |
0,2g【Nota 1】 |
14 |
Metanfetamina |
II-B |
0,2g【Nota 1】 |
15 |
Tetraidrocanabinol (delta-9-THC) |
II-B |
0,05g |
16 |
Ketamina |
II-C |
0,6g【Nota 3-(1)】 |
Notas:
1. As quantidades de referência indicadas foram estabelecidas com base em dados da Junta Internacional de Fiscalização de Estupefacientes (INCB – International Narcotics Control Board).
2. As quantidades de referência indicadas foram estabelecidas com base em dados epidemiológicos referentes ao uso habitual.
3. As quantidades de referência indicadas referem-se:
(1) Às doses diárias mencionadas nos formulários oficiais de medicamentos;
(2) Às doses equipotentes à da substância de abuso de referência;
(3) À dose média diária com base na variação do conteúdo médio do THC existente nos produtos da Canabis;
(4) A uma concentração média de 10% de delta-9-THC;
(5) A uma concentração média de 20% de delta-9-THC;
(6) Às doses médias habituais referidas na literatura, que variam entre 80 mg e 160 mg (ca. 2 mg/kg) da substância pura. No entanto, pode aparecer misturada com impurezas (por exemplo, MDA, cafeína) ou ainda em associação com heroína.
4. Para a cocaína são especificadas doses diferentes, respectivamente para o cloridrato e para o éster metílico de benzoilecgonina, uma vez que existe uma evidente diferença na potência aditiva das duas composições químicas.
ANEXO III
(a que se refere o n.º 2 do artigo 3.º)
Tabela I-A |
|||
N.º |
Denominação em chinês |
Denominação em português |
Denominação / Composição química |
1 |
乙酰阿法甲基芬太尼 |
Acetil-alfa-metilfentanil |
N-[1-(α-methylphenethyl)-4-piperidyl]acetanilide |
2 |
醋氫可待因 |
Acetildiidrocodeína |
3-methoxy-4,5-epoxy-6-acetoxy-17-methylmorphinan |
3 |
醋美沙朵 |
Acetilmetadol |
3-acetoxy-6-dimethylamino-4,4-diphenylheptane |
4 |
醋托啡 |
Acetorfina |
3-O-acetyltetrahydro-7α-(1-hydroxy-1-methylbutyl)-6,14-endo-ethenooripavine |
5 |
阿醋美沙朵 |
Alfacetilmetadol |
α-3-acetoxy-6-dimethylamino-4,4-diphenylheptane |
6 |
阿法美羅定 |
Alfameprodina |
α-3-ethyl-1-methyl-4-phenyl-4-propionoxypiperidine |
7 |
阿法美沙朵 |
Alfametadol |
α-6-dimethylamino-4,4-diphenyl-3-heptanol |
8 |
阿法甲基芬太尼 |
alfa-Metilfentanil |
N-[1-(α-methylphenethyl)-4-piperidyl]propionanilide |
9 |
阿法甲基硫代芬太尼 |
alfa-Metiltiofentanil |
N-{1-[1-methyl-2-(2-thienyl)ethyl]-4-piperidyl}propionanilide |
10 |
阿法羅定 |
Alfaprodina |
α-1,3-dimethyl-4-phenyl-4-propionoxypiperidine |
11 |
阿芬太尼 |
Alfentanil |
N-{1-[2-(4-ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-yl)ethyl]-4-(methoxymethyl)-4-piperidinyl}-N-phenylpropanamide |
12 |
烯丙羅定 |
Alilprodina |
3-allyl-1-methyl-4-phenyl-4-propionoxypiperidine |
13 |
阿尼利定 |
Anileridina |
1-p-aminophenethyl-4-phenylpiperidine-4-carboxylic acid ethyl ester |
14 |
苄替啶 |
Benzetidina |
1-(2-benzyloxyethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester |
15 |
苄嗎啡 |
Benzilmorfina |
3-benzylmorphine |
16 |
倍醋美沙朵 |
Betacetilmetadol |
β-3-acetoxy-6-dimethylamino-4,4-diphenylheptane |
17 |
倍他羥基芬太尼 |
beta-Hidroxifentanil |
N-[1-(β-hydroxyphenethyl)-4-piperidyl]propionanilide |
18 |
倍他羥基-3-甲基芬太尼 |
beta-Hidroxi-3-metilfentanil |
N-[1-(β-hydroxyphenethyl)-3-methyl-4-piperidyl]propionanilide |
19 |
倍他美羅定 |
Betameprodina |
β-3-ethyl-1-methyl-4-phenyl-4-propionoxypiperidine |
20 |
倍他美沙朵 |
Betametadol |
β-6-dimethylamino-4,4-diphenyl-3-heptanol |
21 |
倍他羅定 |
Betaprodina |
β-1,3-dimethyl-4-phenyl-4-propionoxypiperidine |
22 |
貝齊米特 |
Bezitramida |
1-(3-cyano-3,3-diphenylpropyl)-4-(2-oxo-3-propionyl-1-benzimidazolinyl)piperidine |
23 |
嗎苯丁酯 |
Butirato de dioxafetilo |
ethyl-4-morpholino-2,2-diphenylbutyrate |
24 |
凱托米酮 |
Cetobemidona |
4-m-hydroxyphenyl-1-methyl-4-propionylpiperidine |
25 |
氯尼他秦 |
Clonitazeno |
2-(p-chlorobenzyl)-1-diethylaminoethyl-5-nitrobenzimidazole |
26 |
可待因 |
Codeína |
3-methylmorphine |
27 |
可待因-N-氧化物 |
Codeína-N-óxido |
morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, 17-oxide |
28 |
可多克辛 |
Codoxina |
dihydrocodeinone-6-carboxymethyloxime |
29 |
罌粟稈濃縮物 |
Concentrado de palha de papoila |
|
30 |
地索嗎啡 |
Desomorfina |
dihydrodesoxymorphine |
31 |
右嗎拉胺 |
Dextromoramida |
(+)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)butyl]morpholine |
32 |
右丙氧芬 |
Dextropropoxifeno |
α-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-butanol propionate |
33 |
地恩丙胺 |
Diampromida |
N-[2-(methylphenethylamino)-propyl]propionanilide |
34 |
二乙噻丁 |
Dietiltiambuteno |
3-diethylamino-1,1-di-(2’-thienyl)-1-butene |
35 |
地芬諾酯 |
Difenoxilato |
1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester |
36 |
地芬諾辛 |
Difenoxina |
1-(3-cyano-3,3-diphenylpropyl)-4-phenylisonipecotic acid |
37 |
雙氫可待因 |
Diidrocodeína |
(5α,6α)-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol |
38 |
二氫埃托啡 |
Diidroetorfina |
7,8-dihydro-7α-[1-(R)-hydroxy--1-methylbutyl]-6,14-endo-ethanotetrahydrooripavine |
39 |
雙氫嗎啡 |
Di-hidromorfina |
(5α,6α)-4,5-epoxy-17-methylmorphinan-3,6-diol |
40 |
地美庚醇 |
Dimefeptanol |
6-dimethylamino-4,4-diphenyl-3-heptanol |
41 |
地美沙朵 |
Dimenoxadol |
2-dimethylaminoethyl-1-ethoxy-1,1-diphenylacetate |
42 |
二甲噻丁 |
Dimetiltiambuteno |
3-dimethylamino-1,1-di-(2’-thienyl)-1-butene |
43 |
地匹哌酮 |
Dipipanona |
4,4-diphenyl-6-piperidine-3-heptanone |
44 |
羥蒂巴酚 |
Drotebanol |
3,4-dimethoxy-17-methylmorphinan-6β,14-diol |
45 |
乙甲噻丁 |
Etilmetiltiambuteno |
3-ethylmethylamino-1,1-di-(2’-thienyl)-1-butene |
46 |
乙基嗎啡 |
Etilmorfina |
3-ethylmorphine |
47 |
依托尼秦 |
Etonitazeno |
1-diethylaminoethyl-2-p-ethoxybenzyl-5-nitrobenzimidazole |
48 |
埃托啡 |
Etorfina |
tetrahydro-7α-(1-hydroxy-1-methylbutyl)-6, 14-endo-ethenooripavine |
49 |
依托利定 |
Etoxeridina |
1-[2-(2-hydroxyethoxy)-ethyl]-4-phenylpiperidine-4-carboxylic acid ethyl ester |
50 |
苯嗎庚酮 |
Fenadoxona |
6-morpholino-4,4-diphenyl-3-heptanone |
51 |
非那丙胺 |
Fenanpromida |
N-(1-methyl-2-piperidinoethyl)propionanilide |
52 |
非那佐辛 |
Fenazocina |
2’-hydroxy-5,9-dimethyl-2-phenethyl-6,7-benzomorphan |
53 |
非諾啡烷 |
Fenomorfano |
3-hydroxy-N-phenethylmorphinan |
54 |
苯哌利定 |
Fenopiridina |
1-(3-hydroxy-3-phenylpropyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester |
55 |
芬太尼 |
Fentanil |
1-phenethyl-4-N-propionylanilinopiperidine |
56 |
福爾可定 |
Folcodina |
morpholinylethylmorphine |
57 |
呋替啶 |
Furetidina |
1-(2-tetrahydrofurfuryloxyethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester |
58 |
海洛因 |
Heroína |
diacetylmorphine |
59 |
氫可酮 |
Hidrocodona |
dihydrocodeinone |
60 |
氫嗎啡醇 |
Hidromorfinol |
14-hydroxydihydromorphine |
61 |
氫嗎啡酮 |
Hidromorfona |
dihydromorphinone |
62 |
羥哌替啶 |
Hidroxipetidina |
4-m-hydroxyphenyl-1-methylpiperidine-4-carboxylic acid ethyl ester |
63 |
異美沙酮 |
Isometadona |
6-dimethylamino-5-methyl-4,4-diphenyl-3-hexanone |
64 |
左芬啡烷 |
Levofenacilmorfano |
(–)-3-hydroxy-N-phenacylmorphinan |
65 |
左美沙芬* |
Levometorfano* |
(–)-3-methoxy-N-methylmorphinan |
66 |
左嗎拉胺 |
Levomoramide |
(–)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)butyl]morpholine |
67 |
左啡諾* |
Levorfanol* |
(–)-3-hydroxy-N-methylmorphinan |
68 |
美沙酮 |
Metadona |
6-dimethylamino-4,4-diphenyl-3-heptanone |
69 |
美沙酮中間體 |
Metadona, intermediário de |
4-cyano-2-dimethylamino-4,4-diphenylbutane |
70 |
美他佐辛 |
Metazocina |
2’-hydroxy-2,5,9-trimethyl-6,7-benzomorphan |
71 |
甲地索啡 |
Metildesorfina |
6-methyl-Δ6-deoxymorphine |
72 |
甲二氫嗎啡 |
Metildiidromorfina |
6-methyldihydromorphine |
73 |
3-甲基芬太尼 |
3-metilfentanil |
N-(3-methyl-1-phenethyl-4-piperidyl)propionanilide |
74 |
3-甲基硫代芬太尼 |
3-metiltiofentanil |
N-{3-methyl-1-[2-(2-thienyl)ethyl]-4-piperidyl}propionanilide |
75 |
美托酮 |
Metopão |
5-methyldihydromorphinone |
76 |
麥羅啡 |
Mirofina |
myristylbenzylmorphine |
77 |
嗎拉胺中間體 |
Moramida, intermediário de |
2-methyl-3-morpholino-1,1-diphenylpropane carboxylic acid |
78 |
嗎哌利定 |
Morferidina |
1-(2-morpholinoethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester |
79 |
嗎啡 |
Morfina |
(5α,6α)-7,8-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol |
80 |
嗎啡甲溴化物(和其他五價氮嗎啡衍生物,特别包括嗎啡-N-氧化物的衍生物,其中一種是可待因-N-氧化物) |
Bromometilato de morfina (e outros derivados da morfina com azoto pentavalente, incluindo particularmente derivados de N-óxido de morfina, entre os quais N-óxido de codeína) |
|
81 |
嗎啡-N-氧化物 |
Morfina-N-óxido |
(5α,6α)-7,8-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol-17-oxide |
82 |
1-甲基-4-苯基-4-哌啶丙酸酯 |
MPPP |
1-methyl-4-phenyl-4-piperidinol propionate (ester) |
83 |
尼可待因 |
Nicocodina |
6-nicotinylcodeine |
84 |
尼可嗎啡 |
Nicomorfina |
3,6-dinicotinylmorphine |
85 |
尼二氫可待因 |
Nicodicodina |
6-nicotinyldihydrocodeine |
86 |
諾美沙朵 |
Noracimetadol |
(±)-α-3-acetoxy-6-methylamino-4,4-diphenylheptane |
87 |
去甲可待因 |
Norcodeína |
N-demethylcodeine |
88 |
去甲左啡諾 |
Norlevorfanol |
(–)-3-hydroxymorphinan |
89 |
去甲美沙酮 |
Normetadona |
6-dimethylamino-4,4-diphenyl-3-hexanone |
90 |
去甲嗎啡 |
Normorfina |
demethylmorphine |
91 |
諾匹哌酮 |
Norpipanona |
4,4-diphenyl-6-piperidino-3-hexanone |
92 |
阿片 |
Ópio |
|
93 |
阿片 |
Ópio |
|
94 |
羥考酮 |
Oxicodona |
14-hydroxydihydrocodeinone |
95 |
羥嗎啡酮 |
Oximorfona |
14-hydroxydihydromorphinone |
96 |
對氟代芬太尼 |
para-Fluorofentanil |
4’-fluoro-N-(1-phenethyl-4-piperidyl)propionanilide |
97 |
1-苯乙基-4-苯基-4-哌啶乙酸酯 |
PEPAP |
1-phenethyl-4-phenyl-4-piperidinol acetate (ester) |
98 |
哌替啶 |
Petidina |
1-methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester |
99 |
哌替啶中間體A |
Petidina, intermediário A da |
4-cyano-1-methyl-4-phenylpiperidine |
100 |
哌替啶中間體B |
Petidina, intermediário B da |
4-phenylpiperidine-4-carboxylic acid ethyl ester |
101 |
哌替啶中間體C |
Petidina, intermediário C da |
1-methyl-4-phenylpiperidine-4-carboxylic acid |
102 |
匹米諾定 |
Piminodina |
4-phenyl-1-(3-phenylaminopropyl)piperidine-4-carboxylic acid ethyl ester |
103 |
哌腈米特 |
Piritramida |
1-(3-cyano-3,3-diphenylpropyl)-4-(1-piperidino)piperidine-4-carboxylic acid amide |
104 |
普羅庚嗪 |
Pro-heptazina |
1,3-dimethyl-4-phenyl-4-propionoxyazacycloheptane |
105 |
丙哌利定 |
Properidina |
1-methyl-4-phenylpiperidine-4-carboxylic acid isopropyl ester |
106 |
丙吡胺 |
Propirano |
N-(1-methyl-2-piperidinoethyl)-N-2-pyridylpropionamide |
107 |
消旋甲啡烷 |
Racemétorfano |
(±)-3-methoxy-N-methylmorphinan |
108 |
外消旋嗎拉胺 |
Racemoramida |
(±)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)butyl]morpholine |
109 |
消旋啡烷 |
Racemorfano |
(±)-3-hydroxy-N-methylmorphinan |
110 |
瑞芬太尼 |
Remifentanilo |
1-(2-methoxycarbonylethyl)-4- (phenylpropionylamino)-piperidine-4- carboxylic acid methyl ester |
111 |
舒芬太尼 |
Sufentanil |
N-{4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidyl}propionanilide |
112 |
醋氫可酮 |
Tabecão |
acetyldihydrocodeinone |
113 |
蒂巴因 |
Tebaína |
(5α)-6,7,8,14-tetradehydro-4,5-epoxy-3, 6-dimethoxy-17-methylmorphinan |
114 |
替利定 |
Tilidina |
(±)-ethyl-trans-2-(dimethylamino)-1-phenyl-3-cyclohexene-1-carboxylate |
115 |
硫代芬太尼 |
Tiofentanil |
N-{1-[2-(2-thienyl)ethyl]-4-piperidyl}propionanilide |
116 |
三甲利定 |
Trimeperidina |
1,2,5-trimethyl-4-phenyl-4-propionoxypiperidine |
117 |
AH-7921 |
AH-7921 |
3,4-dichloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide |
118 |
乙酰芬太尼 |
Acetylfentanyl |
N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]acetamide |
119 |
MT-45 |
MT-45 |
1-cyclohexyl-4-(1,2-diphenylethyl)piperazine |
120 |
U-47700 |
U-47700 |
3,4-dichloro-N-(2-dimethylamino-cyclohexyl)-N-methyl-benzamide |
121 |
丁苯芬 |
Butyrfentanyl |
N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]butanamide |
122 |
卡芬太尼 |
Carfentanil |
methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate |
123 |
奧芬太尼 |
Ocfentanil |
N-(2-fluorophenyl)-2-methoxy-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide |
124 |
呋喃芬太尼 |
Furanylfentanyl |
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide |
125 |
丙烯酰芬太尼 |
Acryloylfentanyl, Acrylfentanyl |
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]prop-2-enamide |
126 |
4-氟異丁基芬太尼 |
4-Fluoroisobutyrfentanyl, |
N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide |
127 |
四氫呋喃芬太尼 |
Tetrahydrofuranylfentanyl, |
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]tetrahydrofuran-2-carboxamide |
128 |
對氟丁酰芬太尼 |
Parafluorobutyrylfentanyl |
N-(4-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]butanamide |
129 |
甲氧基乙酰芬太尼 |
Methoxyacetylfentanyl |
2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide |
130 |
環丙基芬太尼 |
Cyclopropylfentanyl |
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide |
131 |
巴豆酰芬太尼 |
Crotonylfentanyl |
(E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide |
132 |
戊酰芬太尼 |
Valerylfentanyl |
N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide |
133 |
奧列巴文 |
Oripavina |
3-O-demethylthebaine |
134 |
鄰氟芬太尼 |
Orthofluorofentanyl |
N-(2-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide |
135 |
異硝氮烯 |
Isotonitazene |
N,N-diethyl-2-[2-(4-isopropoxybenzyl)-5--nitro-1H-benzo[d]imidazol-1-yl]ethan-1-amine |
136 |
溴啡 |
Brorphine |
1-{1-[1-(4-bromophenyl)ethyl]-piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one |
137 |
甲硝苯 |
Metonitazene |
N,N-diethyl-2-[2-(4-methoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl]ethan-1-amine |
列於本附表內物質在其特定化學名稱下可能存在的異構體,但明確不列入本附表的異構體除外。 |
|||
列於本附表內物質的各形式酯類及醚類,但不包括列於其他附表的酯類及醚類。 |
|||
列於本附表內物質的鹽類,包括上述酯類、醚類及異構體的鹽類,只要該等鹽類的形式屬可能。 |
|||
*右美沙芬及右啡烷均明確不列入本附表內。 |
Tabela I-B |
|||
N.º |
Denominação em chinês |
Denominação em português |
Denominação / |
1 |
古柯葉 |
Coca, folha de |
|
2 |
可卡因 |
Cocaína |
methyl ester of benzoylecgonine |
3 |
可卡因-D |
Cocaína-D |
|
4 |
芽子鹼 |
Ecgonina |
|
本附表所列複合物的所有可能存在的鹽類,均視為列入本附表內。 |
Tabela I-C |
|||
N.º |
Denominação em chinês |
Denominação em português |
Denominação / |
1 |
大麻 |
Canabis |
|
2 |
大麻樹脂 |
Canabis, resina de |
|
3 |
大麻油 |
Canabis, óleo de |
|
本附表所列複合物的所有可能存在的鹽類,均視為列入本附表內。 |
Tabela II-A |
|||
N.º |
Denominação em chinês |
Denominação em português |
Denominação / Composição química |
1 |
2,5-二甲氧基-4-溴苯乙胺 |
2C-B |
4-bromo-2,5-dimethoxyphenethylamine |
2 |
2,5-二甲氧基-4-丙硫基苯乙胺 |
2C-T-7 |
4-propylthio-2,5-dimethoxyphenethylamine |
3 |
蟾酥鹼 |
Bufotenina |
3-[2-(dimethylamino)ethyl]-1H-indol-5-ol |
4 |
卡西酮 |
Catinona |
(–)-(S)-2-aminopropiophenone |
5 |
二乙基色胺 |
DET |
3-[2-(diethylamino)ethyl]indole |
6 |
二甲氧基苯丙胺 |
DMA |
(±)-2,5-dimethoxy-α-methylphenethylamine |
7 |
(1,2-二甲基庚基)羥基四氫甲基二苯吡喃 |
DMHP |
3-(1,2-dimethylheptyl)-7,8,9,10-tetrahydro- 6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol |
8 |
二甲基色胺 |
DMT |
3-[2-(dimethylamino)ethyl]indole |
9 |
布苯丙胺 |
Brolanfetamina, |
(±)-4-bromo-2,5-dimethoxy-α-methylphenethylamine |
10 |
二甲氧基乙基苯丙胺 |
DOET |
(±)-4-ethyl-2,5-dimethoxy-α-methylphenethylamine |
11 |
二甲氧基甲苯異丙胺 |
STP, |
2,5-dimethoxy-α,4-dimethylphenethylamine |
12 |
二丙色胺 |
DPT |
N,N-dipropyltryptamine |
13 |
乙環利定 |
Eticiclidina, |
N-ethyl-1-phenylcyclohexylamine |
14 |
乙色胺 |
Etriptamina |
3-(2-aminobutyl)indole |
15 |
苯環利定 |
Fenciclidina, |
1-(1-phenylcyclohexyl)piperidine |
16 |
麥角二乙胺, |
(+)-Lisergida, |
9,10-didehydro-N,N-diethyl-6-methylergoline- -8β-carboxamide |
17 |
替苯丙胺 |
Tenanfetamina, |
α-methyl-3,4-(methylenedioxy)phenethylamine |
18 |
亞甲二氧基甲基苯丙胺 |
MDMA |
(±)-N,α-dimethyl-3,4-(methylenedioxy)phenethylamine |
19 |
甲羥芬胺 |
MMDA |
5-methoxy-α-methyl-3,4-(methylenedioxy)phenethylamine |
20 |
麥司卡林 |
Mescalina |
3,4,5-trimethoxyphenethylamine |
21 |
甲米雷司 |
4-Metilaminorex |
(±)-cis-2-amino-4-methyl-5-phenyl-2-oxazoline |
22 |
甲卡西酮 |
Metcatinona |
2-(methylamino)-1-phenylpropan-1-one |
23 |
4-甲硫苯丙胺 |
4-MTA |
α-methyl-4-methylthiophenethylamine |
24 |
乙芬胺 |
N-etil MDA, |
(±)-N-ethyl-α-methyl-3,4-(methylenedioxy)phenethylamine |
25 |
羥芬胺 |
N-hidroxi MDA |
(±)-N-[α-methyl-3,4-(methylenedioxy)phenethyl]hydroxylamine |
26 |
六氫大麻酚 |
Para-hexilo |
3-hexyl-7,8,9,10-tetrahydro-6,6,9-trimethyl- 6H-dibenzo[b,d]pyran-1-ol |
27 |
PMA |
PMA |
1-(4-methoxyphenyl)propan-2-amine |
28 |
副甲氧基甲基苯丙胺 |
PMMA |
1-(4-methoxyphenyl)-2-methylaminopropane |
29 |
賽洛西賓 |
Psilocibina |
3-[2-(dimethylamino)ethyl]indol-4-yl dihydrogen phosphate |
30 |
賽洛新 |
Psilocina, |
3-[2-(dimethylamino)ethyl]indol-4-ol |
31 |
咯環利定 |
Roliciclidina, |
1-(1-phenylcyclohexyl)pyrrolidine |
32 |
替諾環定 |
Tenociclidina, |
1-[1-(2-thienyl)cyclohexyl]piperidine |
33 |
三甲氧基苯丙胺 |
TMA |
(±)-3,4,5-trimethoxy-α-methylphenethylamine |
34 |
卡西酮的衍生物* (不包括已列於各附表的物質) - 任何在結構上可從2-氨基-1-苯基-1-丙酮通過以下任何方式衍生成的化合物: (1)在苯環上以不限數量的烷基、烷氧基、亞烷二氧基、鹵代烷基或鹵素取代,而不論生成物有否再在苯環上被一個或多個的單價取代基所取代; (2)在3-位上以烷基取代; (3)在氮原子上以烷基、雙烷基取代,或把氮原子納入一個環狀結構。 - 任何在結構上可從2-氨基-1-丙酮的1-位上以各種單環或稠環(不包括苯環或亞烷二氧苯環)衍生成的化合物,不論其有否再用以下任何方式作取代: (1)在單環或稠環上以不限數量的烷基、烷氧基、鹵代烷基或鹵素取代,而不論生成物有否再在環上被一個或多個的單價取代基所取代; (2)在3-位上以烷基取代; (3)在2-氨基的氮原子上以烷基或雙烷基取代,或把2-氨基的氮原子納入一個環狀結構。 |
Derivados da Catinona* (salvo se as substâncias figurarem noutra tabela) - Qualquer composto derivado estruturalmente da 2-amino-1-phenyl-1-propanone por modificação de qualquer das seguintes formas: (1) por substituição de qualquer extensão no anel fenil pelos substituintes alcoíl, alcóxi, alquillenedioxi, haloalquil ou haleto, quer seja ou não ainda mais substituída no anel fenil por um ou mais substituintes univalentes; (2) por substituição na posição-3 com um substituinte alcoíl; (3) por substituição no átomo de azoto com os grupos alcoíl ou dialcoíl, ou por inclusão do átomo de azoto numa estrutura cíclica. - Qualquer composto derivado estruturalmente da 2-aminopropan-1-one por substituição na posição-1 por qualquer sistema anelar monocíclico, ou policíclicos-fundidos (sem ser um sistema anelar fenil ou alquillenedioxifenil), se o composto é ou não: (1) por substituição de qualquer extensão no sistema anelar monocíclico, ou policíclicos-fundidos com substituintes alcoíl, alcóxi, haloalquil ou haleto, quer seja ou não ainda mais substituída no sistema anelar por um ou mais substituintes univalentes; (2) por substituição na posição-3 por qualquer substituinte alcoíl; (3) por substituição do átomo 2-amino nitrogen pelos grupos alcoíl ou dialcoíl ou por inclusão do átomo 2-amino nitrogen numa estrutura cíclica. |
|
35 |
哌嗪的衍生物 - 1-苄基哌嗪 - 任何在結構上可從1-苄基哌嗪或1-苯基哌嗪通過以下任何方式衍生成的化合物: (1)在哌嗪環的第2位氮原子上以烷基、苄基、鹵代烷基或苯基取代; (2)在芳香環上以不限數量的烷基、烷氧基、亞烷二氧基、鹵基或鹵代烷基取代。 |
Derivados da Piperazina - 1-Benzilpiperazina - Qualquer composto estruturalmente derivado da 1-benzilpiperazina ou 1-fenilpiperazina por modificação de qualquer das seguintes maneiras: (1) por substituição do segundo átomo de azoto no anel piperazina com os grupos alcoíl, benzil, haloalquíl ou fenil; (2) por substituição em qualquer extensão do anel aromático com os grupos alcoíl, alcóxi alquilenedioxi, haleto ou haloalquil. |
|
36 |
墨西哥鼠尾草 |
Salvia divinorum |
|
37 |
丹酚-A |
Salvinorina-A |
(2S,4aR,6aR,7R,9S,10aS,10bR)-9-(acetyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-2H-naphtho[2,1-c]pyran-7-carboxylic acid methyl ester |
38 |
25B-NBOMe |
25B-NBOMe |
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine |
39 |
25C-NBOMe |
25C-NBOMe |
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine |
40 |
25I-NBOMe |
25I-NBOMe |
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine |
41 |
副甲基甲米雷司 |
para-Methyl-4-methylaminorex, |
4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3--oxazol-2-amine |
42 |
DOC |
DOC |
4-chloro-2,5-dimethoxyamfetamine |
43 |
3-甲氧基苯環利定 |
3-Methoxyphencyclidine |
1-[1-(3-methoxyphenyl)cyclohexyl]piperidine |
44 |
二苯基乙基哌啶 |
Diphenidine |
1-(1,2-diphenylethyl)piperidine |
列於本附表內物質的可能存在的鹽類。 |
|||
列於本附表內物質在其特定化學名稱下可能存在的異構體,但明確不列入本附表的異構體除外。 |
|||
*卡西酮的衍生物中,安非他酮明確不列入本附表內。 |
Tabela II-B |
|||
N.º |
Denominação em chinês |
Denominação em português |
Denominação / Composição química |
1 |
安咪奈丁 |
Amineptina |
7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid |
2 |
苯丙胺 |
Anfetamina |
(±)-α-methylphenethylamine |
3 |
去甲偽麻黃鹼, |
Catina, |
(+)-(S)-α-[(S)-1-aminoethyl]benzyl alcohol |
4 |
右苯丙胺 |
Dexanfetamina |
(+)-α-methylphenethylamine |
5 |
屈大麻酚, |
Dronabinol, |
(6aR,10aR)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol |
6 |
苯甲曲秦 |
Fendimetrazina |
(+)-(2S,3S)-3,4-dimethyl-2-phenylmorpholine |
7 |
芬乙茶鹼 |
Fenetilina |
7- {2-[(α-methylphenethyl)amino]ethyl} theophylline |
8 |
芬美曲秦 |
Fenmetrazina |
3-methyl-2-phenylmorpholine |
9 |
芬特明 |
Fentermina |
α,α-dimethylphenethylamine |
10 |
左苯丙胺 |
Levanfetamina |
(–)-(R)-α-methylphenethylamine |
11 |
左甲苯丙胺 |
Levometanfetamina |
(–)-N,α-dimethylphenethylamine |
12 |
甲基苯丙胺 |
Metanfetamina |
(+)-(S)-N,α-dimethylphenethylamine |
13 |
甲基苯丙胺外消旋體 |
Racemato de metanfetamina |
(±)-N,α-dimethylphenethylamine |
14 |
哌醋甲酯 |
Metilfenidato |
methyl α-phenyl-2-piperidine acetate |
15 |
N,N-二甲基安非他明 |
N,N-dimetanfetamina |
N,N-dimethylamphetamine |
16 |
四氫大麻酚 |
Tetraidrocanabinol |
|
delta-6a(10a)-THC |
delta-6a(10a)-THC |
7,8,9,10-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol |
|
delta-6a(7)-THC |
delta-6a(7)-THC |
(9R,10aR)-8,9,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol |
|
delta-7-THC |
delta-7-THC |
(6aR,9R,10aR)-6a,9,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol |
|
delta-8-THC |
delta-8-THC |
(6aR,10aR)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol |
|
delta-10-THC |
delta-10-THC |
6a,7,8,9-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol |
|
delta-9(11)-THC |
delta-9(11)-THC |
(6aR,10aR)-6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-9-methylene-3-pentyl-6H-dibenzo[b,d]pyran-1-ol |
|
17 |
齊培丙醇 |
Zipeprol |
α-(α-methoxybenzyl)-4-(β-methoxyphenethyl)--1-piperazineethanol |
18 |
合成大麻素 - 任何在結構上可從3-(1-萘甲酰基)吲哚或1H-吲哚-3-基-1-萘甲烷通過在吲哚環的氮原子上以烷基、鏈烯基、環烷甲基、環烷乙基或2-(4-嗎啉基)乙基取代所生成的化合物,而不論生成物有否再在吲哚環或萘環以不限數量取代 - 任何在結構上可從3-(1-萘甲酰基)吡咯通過在吡咯環的氮原子上以烷基、鏈烯基、環烷甲基、環烷乙基或2-(4-嗎啉基)乙基取代所生成的化合物,而不論生成物有否再在吡咯環或萘環以不限數量取代 - 任何在結構上可從1-(1-萘亞甲基)茚通過在茚環的3-位上以烷基、鏈烯基、環烷甲基、環烷乙基或2-(4-嗎啉基)乙基取代所生成的化合物,而不論生成物有否再在茚環或萘環以不限數量取代 - 任何在結構上可從3-苯乙酰基吲哚通過在吲哚環的氮原子上以烷基、鏈烯基、環烷甲基、環烷乙基或2-(4-嗎啉基)乙基取代所生成的化合物,而不論生成物有否再在吲哚環或苯環以不限數量取代 - 任何在結構上可從2-(3-羥基環己基)酚通過在酚環的5-位上以烷基、鏈烯基、環烷甲基、環烷乙基或2-(4-嗎啉基)乙基取代所生成的化合物,而不論生成物有否再在己基環以不限數量取代 |
Canabinoides sintéticos - Qualquer composto derivado estruturalmente do 3-(1-naphthoyl)indole ou 1H-indol-3-yl-(1-naphthyl)methane por substituição no átomo de azoto do anel indole por alcoíl, alceno, cicloalcoílmetil, cicloalcoíletil ou 2-(4-morfolinil)etil, quer seja ou não ainda mais substituído em qualquer extensão do anel indole quer seja ou não ainda mais substituído em qualquer extensão do anel naftaleno - Qualquer composto derivado estruturalmente do 3-(1-naphthoyl)pyrrole por substituição no átomo de azoto do anel pirrol por alcoíl, alceno, cicloalcoílmetil, cicloalcoíletil ou 2-(4-morpholinyl)ethyl, quer seja ou não ainda mais substituído em qualquer extensão do anel pirrol, quer seja ou não ainda mais substituído em qualquer extensão do anel naftaleno - Qualquer composto derivado estruturalmente do 1-(1-naphthylmethylene)indene por substituição na posição-3 do anel indeno por alcoíl, alceno, cicloalcoílmetil, cicloalcoíletil ou 2-(4-morpholinyl)ethyl, quer seja ou não ainda mais substituído em qualquer extensão do anel pirrol, quer seja ou não ainda mais substituído em qualquer extensão do anel naphthyl - Qualquer composto derivado estruturalmente do 3-phenylacetylindole por substituição no átomo de azoto do anel indole por alcoíl, alceno, cicloalcoílmetil, cicloalcoíletil ou 2-(4-morpholinyl)ethyl, quer seja ou não ainda mais substituído em qualquer extensão do anel indole e quer seja ou não substituído em qualquer extensão do anel fenil - Qualquer composto derivado estruturalmente do 2-(3-hydroxycyclohexyl)phenol por substituição na posição-5 do anel fenól por alcoíl, alceno, cicloalcoílmetil, cicloalcoíletil ou 2-(4-morpholinyl)ethyl, quer seja ou não ainda mais substituído em qualquer extensão do anel ciclohexil |
|
19 |
1-(1-萘甲酰基)-4-戊氧基萘 |
CRA-13, |
naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone |
20 |
AM-2201, |
AM-2201, |
[1-(5-fluoropentyl)-1H-indol-3-yl](naphthalen--1-yl)methanone |
21 |
哌乙酯 |
Ethylphenidate |
ethyl 2-phenyl-2-(piperidin-2-yl)acetate |
22 |
Methiopropamine, |
Methiopropamine, |
1-(thiophen-2-yl)-2-methylaminopropane |
23 |
MDMB-CHMICA |
MDMB-CHMICA |
methyl 2-{[1-(cyclohexylmethyl)indole-3-carbonyl]amino}-3,3-dimethylbutanoate |
24 |
5F-APINACA, |
5F-APINACA, |
N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide |
25 |
XLR-11 |
XLR-11 |
[1-(5-fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone |
26 |
N-(1-氨甲酰基-2-甲基丙基)-1-(環己基甲基)-吲唑-3-甲酰胺 |
AB-CHMINACA |
N-[(2S)-1-amino-3-methyl-oxobutan-2-yl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide |
27 |
5F-ADB, |
5F-ADB, |
methyl(2S)-2-{[1-(fluoropentyl)-1H-indazole--3-carbonyl]amino}-3,3-dimethylbutanoate |
28 |
AB-PINACA |
AB-PINACA |
N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]-1-pentyl-1H-indazole-3-carboxamide |
29 |
UR-144 |
UR-144 |
(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone |
30 |
5F-PB-22 |
5F-PB-22 |
quinolin-8-yl 1-(5-fluoropentyl)-1H-indole--3-carboxylate |
31 |
4-氟苯丙胺 |
4-Fluoroamphetamine, 4-FA |
1-(4-fluorophenyl)propan-2-amine |
32 |
ADB-FUBINACA |
ADB-FUBINACA |
N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide |
33 |
FUB-AMB, |
FUB-AMB, |
methyl(2S)-2-({1-[(4-fluorophenyl)methyl]-1H--indazole-3-carbonyl}amino)-3-methylbutanoate |
34 |
CUMYL-4CN-BINACA |
CUMYL-4CN-BINACA |
1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide |
35 |
ADB-CHMINACA, |
ADB-CHMINACA, |
N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide |
36 |
AB-FUBINACA |
AB-FUBINACA |
N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]- -1-[(4-fluorophenyl)methyl]indazole-3-carboxamide |
37 |
5F-AMB, |
5F-AMB, |
methyl 2-({[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl}amino)-3-methylbutanoate |
38 |
5F-MDMB-PICA |
5F-MDMB-PICA |
methyl(S)-2-[1-(5-fluoropentyl)-1H-indole-3-carboxamido]-3,3-dimethylbutanoate |
39 |
4F-MDMB-BINACA |
4F-MDMB-BINACA |
methyl(S)-2-[1-(4-fluorobutyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate |
40 |
CUMYL-PEGACLON |
CUMYL-PEGACLON |
5-pentyl-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one |
41 |
MDMB-4en-PINACA |
MDMB-4en-PINACA |
methyl 3,3-dimethyl-2-[1-(pent-4-en-1-yl)-1H--indazole-3-carboxamido]butanoate |
列於本附表內物質可能存在的衍生物及鹽類,以及由該等物質配有其他不論其作用如何的複合物調製而成的所有製劑。 |
Tabela II-C |
|||
N.º |
Denominação em chinês |
Denominação em português |
Denominação / Composição química |
1 |
異戊巴比妥 |
Amobarbital |
5-ethyl-5-isopentylbarbituric acid |
2 |
丁丙諾啡 |
Buprenorfina |
21-cyclopropyl-7-α-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo--ethano-6,7,8,14-tetrahydrooripavine |
3 |
布他比妥 |
Butalbital |
5-allyl-5-isobutylbarbituric acid |
4 |
環己巴比妥 |
Ciclobarbital |
5-(1-cyclohexen-1-yl)-5-ethylbarbituric acid |
5 |
γ-羥基丁酸, |
Ácido gama-hidroxibutírico, |
γ-hydroxybutyric acid |
6 |
格魯米特 |
Glutetamida |
2-ethyl-2-phenylglutarimide |
7 |
氯胺酮 |
Ketamina |
(±)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone |
8 |
甲氯喹酮 |
Mecloqualona |
3-(o-chlorophenyl)-2-methyl-4(3H)-quinazolinone |
9 |
甲喹酮 |
Metaqualona |
2-methyl-3-o-tolyl-4(3H)-quinazolinone |
10 |
噴他佐辛 |
Pentazocina |
(2R*,6R*,11R*)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol |
11 |
戊巴比妥 |
Pentobarbital |
5-ethyl-5-(1-methylbutyl)barbituric acid |
12 |
司可巴比妥 |
Secobarbital |
5-allyl-5-(1-methylbutyl)barbituric acid |
13 |
Methoxetamine, |
Methoxetamine, |
(RS)-2-(3-methoxyphenyl)-2-(ethylamino)-cyclohexanone |
14 |
氟胺酮 |
2-Fluorodeschloroketamine, |
2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one |
列於本附表內物質的可能存在的鹽類。 |
Tabela III |
|
1 |
製劑:醋氫可待因;可待因;雙氫可待因;乙基嗎啡;福爾可定;尼可待因;尼二氫可待因;去甲可待因。 |
2 |
丙吡胺製劑:每劑量單位含丙吡胺不超過100毫克並且與至少等量的甲基纖維素相調配。 |
3 |
右丙氧芬製劑:口服製劑,其每劑量單位含有不超過135毫克的右丙氧芬鹼或其濃度不超過整個製劑的2.5%,條件是這類製劑不含有根據《一九七一年精神藥物公約》加以管制的任何物品。 |
4 |
可卡因製劑:所含可卡因以可卡因鹼計算不超過0.1%;和 |
5 |
地芬諾辛製劑:每劑量單位含有不超過0.5毫克的地芬諾辛,並含有至少相當於地芬諾辛劑量5%的硫酸顛茄鹼。 |
6 |
地芬諾酯製劑:每劑量單位含有以鹼計算不超過2.5毫克的地芬諾酯,並含有至少相當於地芬諾酯劑量1%的硫酸顛茄鹼。 |
7 |
複方阿片吐根散製劑: 10%阿片粉; 10%吐根散; 80%不含任何藥物的其他粉狀成分,細混合。 Pó de ipecacuanha e ópio com a seguinte composição: 10% de ópio em pó; 10% de raiz de ipecacuanha em pó; 80% de qualquer pó inerte não contendo droga. |
8 |
符合本附表所列任一配方的製劑及此製劑與不含任何藥物的原料的混合物。 |
Tabela IV |
|||
N.º |
Denominação em chinês |
Denominação em português |
Denominação / Composição química |
1 |
阿洛巴比妥 |
Alobarbital |
5,5-diallylbarbituric acid |
2 |
阿普唑侖 |
Alprazolam |
8-chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine |
3 |
安非拉酮, |
Amfepramona, |
2-(diethylamino)propiophenone |
4 |
阿米雷司 |
Aminorex |
2-amino-5-phenyl-2-oxazoline |
5 |
巴比妥 |
Barbital |
5,5-diethylbarbituric acid |
6 |
苄非他明, |
Benzefetamina |
N-benzyl-N,α-dimethylphenethylamine |
7 |
溴西泮 |
Bromazepam |
7-bromo-1,3-dihydro-5-(2-pyridyl)-2H-1,4-benzodiazepin-2-one |
8 |
溴替唑侖 |
Brotizolam |
2-bromo-4-(o-chlorophenyl)-9-methyl-6H-thieno[3,2-f]-s-triazolo[4,3-a][1,4]diazepine |
9 |
丁巴比妥 |
Butobarbital |
5-butyl-5-ethylbarbituric acid |
10 |
卡馬西泮 |
Camazepam |
7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one dimethylcarbamate (ester) |
11 |
凱他唑侖 |
Cetazolam |
11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-4H-[1,3]oxazino[3,2-d][1,4]benzodiazepin-4,7(6H)-dione |
12 |
氯巴占 |
Clobazam |
7-chloro-1-methyl-5-phenyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione |
13 |
氯硝西泮 |
Clonazepam |
5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one |
14 |
氯拉卓酸 |
Clorazepato |
7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid |
15 |
氯氮卓 |
Clordiazepóxido |
7-chloro-2-(methylamino)-5-phenyl-3H-1,4-benzodiazepine-4-oxide |
16 |
氯噻西泮 |
Clotiazepam |
5-(o-chlorophenyl)-7-ethyl-1,3-dihydro-1-methyl-2H-thieno[2,3-e]-1,4-diazepin-2-one |
17 |
氯噁唑侖 |
Cloxazolam |
10-chloro-11b-(o-chlorophenyl)-2,3,7,11b-tetrahydrooxazolo-[3,2-d][1,4]benzodiazepin-6(5H)-one |
18 |
地洛西泮 |
Delorazepam |
7-chloro-5-(o-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one |
19 |
地西泮 |
Diazepam |
7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one |
20 |
艾司唑侖 |
Estazolam |
8-chloro-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine |
21 |
乙氯維諾 |
Etclorvinol |
1-chloro-3-ethyl-1-penten-4-yn-3-ol |
22 |
乙非他明, |
Etilanfetamina, |
N-ethyl-α-methylphenethylamine |
23 |
氯氟卓乙酯 |
Etiloflazepato |
ethyl 7-chloro-5-(o-fluorophenyl)-2,3-dihydro-2-oxo-1H-1,4-benzodiazepine-3-carboxylate |
24 |
炔己蟻胺 |
Etinamato |
1-ethynylcyclohexanol carbamate |
25 |
芬坎法明 |
Fencanfamina |
N-ethyl-3-phenyl-2-norbornanamine |
26 |
苯巴比妥 |
Fenobarbital |
5-ethyl-5-phenylbarbituric acid |
27 |
芬普雷斯 |
Fenproporex |
(±)-3-[(α-methylphenylethyl)amino]propionitrile |
28 |
氟地西泮 |
Fludiazepam |
7-chloro-5-(o-fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one |
29 |
氟硝西泮 |
Flunitrazepam |
5-(o-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one |
30 |
氟西泮 |
Flurazepam |
7-chloro-1-[2-(diethylamino)ethyl]-5-(o-fluorophenyl)-1,3-dihydro--2H-1,4-benzodiazepin-2-one |
31 |
哈拉西泮 |
Halazepam |
7-chloro-1,3-dihydro-5-phenyl-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepin-2-one |
32 |
鹵沙唑侖 |
Haloxazolam |
10-bromo-11b-(o-fluorophenyl)-2,3,7,11b-tetrahydrooxazolo[3,2-d][1,4]benzodiazepin-6(5H)-one |
33 |
利非他明 |
Lefetamina, |
(–)-N,N-dimethyl-1,2-diphenylethylamine |
34 |
氯普唑侖 |
Loprazolam |
6-(o-chlorophenyl)-2,4-dihydro-2-[(4-methyl-1-piperazinyl)methylene]-8-nitro-1H-imidazo[1,2-a][1,4]benzodiazepin-1-one |
35 |
勞拉西泮 |
Lorazepam |
7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one |
36 |
氯甲西泮 |
Lormetazepam |
7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-1-methyl-2H-1,4-benzodiazepin-2-one |
37 |
馬吲哚 |
Mazindol |
5-(p-chlorophenyl)-2,5-dihydro-3H-imidazo[2,1-a]isoindol-5-ol |
38 |
美達西泮 |
Medazepam |
7-chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepine |
39 |
美芬雷斯 |
Mefenorex |
N-(3-chloropropyl)-α-methylphenethylamine |
40 |
甲丙氨酯 |
Meprobamato |
2-methyl-2-propyl-1,3-propanediol dicarbamate |
41 |
美索卡 |
Mesocarbe |
3-(α-methylphenethyl)-N-(phenylcarbamoyl)sydnone imine |
42 |
甲苯巴比妥 |
Metilfenobarbital |
5-ethyl-1-methyl-5-phenylbarbituric acid |
43 |
甲乙哌酮 |
Metiprilona |
3,3-diethyl-5-methyl-2,4-piperidine-dione |
44 |
咪達唑侖 |
Midazolam |
8-chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine |
45 |
尼美西泮 |
Nimetazepam |
1,3-dihydro-1-methyl-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one |
46 |
硝西泮 |
Nitrazepam |
1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one |
47 |
去甲西泮 |
Nordazepam |
7-chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one |
48 |
奧沙西泮 |
Oxazepam |
7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one |
49 |
奧沙唑侖 |
Oxazolam |
10-chloro-2,3,7,11b-tetrahydro-2-methyl-11b-phenyloxazolo[3,2-d][1,4]benzodiazepin-6(5H)-one |
50 |
匹莫林 |
Pemolina |
2-amino-5-phenyl-2-oxazolin-4-one |
51 |
匹那西泮 |
Pinazepam |
7-chloro-1,3-dihydro-5-phenyl-1-(2-propynyl)-2H-1,4-benzodiazepin--2-one |
52 |
哌苯甲醇 |
Pipradol |
1,1-diphenyl-1-(2-piperidyl)methanol |
53 |
吡咯戊酮 |
Pirovalerona |
4’-methyl-2-(1-pyrrolidinyl)valerophenone |
54 |
普拉西泮 |
Prazepam |
7-chloro-1-(cyclopropylmethyl)-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one |
55 |
六氫脫氧麻黃鹼 |
Propilhexedrina |
1-cyclohexyl-2-methylaminopropane |
56 |
仲丁比妥 |
Secbutabarbital |
5-sec-butyl-5-ethylbarbituric acid |
57 |
替馬西泮 |
Temazepam |
7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one |
58 |
四氫西泮 |
Tetrazepam |
7-chloro-5-(1-cyclohexen-1-yl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one |
59 |
三唑侖 |
Triazolam |
8-chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine |
60 |
乙烯比妥 |
Vinilbital |
5-(1-methylbutyl)-5-vinylbarbituric acid |
61 |
唑吡旦 |
Zolpidem |
N,N,6-trimethyl-2-p-tolylimidazo[1,2-a]pyridine-3-acetamide |
62 |
芬納西泮 |
Phenazepam |
7-bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one |
63 |
氟阿普唑侖 |
Flualprazolam |
8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine |
64 |
依替唑侖 |
Etizolam |
4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine |
65 |
氯氮唑侖 |
Clonazolam |
6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine |
66 |
二氯西泮 |
Diclazepam |
7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one |
67 |
氟溴唑侖 |
Flubromazolam |
8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine |
列於本附表內物質的可能存在的鹽類。 |
Tabela V |
|||
N.º |
Denominação em chinês |
Denominação em português |
Denominação / Composição química |
1 |
醋酸酐 |
Anidrido acético |
acetic oxide |
2 |
N-乙酰鄰氨基苯酸 |
Ácido N-acetilantranílico |
benzoic acid, 2-(acetylamino)- |
3 |
麻黃鹼 |
Efedrina |
[R-(R*,S*)]-α-[1-(methylamino)ethyl]benzenemethanol |
4 |
麥角新鹼 |
Ergometrina |
ergoline-8-carboxamide, 9,10-didehydro-N-(2-hydroxy-1- methylethyl)-6-methyl-, [8β(S)] |
5 |
麥角胺 |
Ergotamina |
ergotaman-3’,6’,18’-trione, 12’-hydroxy-2’-methyl-5’-(phenylmethyl)-, (5α) |
6 |
異黃樟腦 |
Isosafrole |
1,3-benzodioxole, 5-(1-propenyl)- |
7 |
麥角酸 |
Ácido lisérgico |
(8β)-9,10-didehydro-6-methylergoline-8-carboxylic acid |
8 |
3,4-亞甲基二氧苯基-2-丙酮 |
3,4-Metilenodioxifenil-2-propanona |
2-propanone, 1-[3,4-(methylenedioxy)phenyl]- |
9 |
去甲麻黃鹼 |
Norefedrina |
(R*,S*)-α-(1-aminoethyl)benzenemethanol |
10 |
1-苯基-2-丙酮 |
1-Fenil-2-propanona |
1-phenyl-2-propanone |
11 |
胡椒醛 |
Piperonal |
1,3-benzodioxole-5-carboxaldehyde |
12 |
高錳酸鉀 |
Permanganato de potássio |
permanganic acid (HMnO4), potassium salt |
13 |
偽麻黃鹼 |
Pseudoefedrina |
[S-(R*,R*)]-α-[1-(methylamino)ethyl]benzenemethanol |
14 |
黃樟腦 |
Safrole |
1,3-benzodioxole, 5-(2-propenyl)- |
15 |
苯乙酸 |
Ácido fenilacético |
benzeneacetic acid |
16 |
α-苯乙酰乙腈 |
alfa-Fenilacetoacetonitrilo, |
3-oxo-2-phenylbutanenitrile |
17 |
4-苯胺-N-苯乙基哌啶 |
4-Anilino-N-phenethylpiperidine, |
N-phenyl-1-(2-phenylethyl)piperidin-4-amine |
18 |
N-苯乙基-4-哌啶酮 |
N-Phenethyl-4-piperidone, |
1-(2-phenylethyl)-piperidin-4-one |
19 |
3,4-亞甲基二氧苯基-2-丙酮甲基縮水甘油 |
3,4-MDP-2-P methyl glycidate |
2-oxiranecarboxylic acid, 3-(1,3-benzodioxol-5-yl)-2-methyl-, methyl ester |
20 |
3,4-亞甲基二氧苯基-2-丙酮甲基縮水甘油酸 |
3,4-MDP-2-P methyl glycidic acid |
2-oxiranecarboxylic acid, 3-(1,3-benzodioxol-5-yl)-2-methyl- |
21 |
α-乙酰乙酸苯胺 |
alpha-Phenylacetoacetamide, |
benzeneacetamide, α-acetyl- |
22 |
α-苯乙酰乙酸甲酯 |
Methyl alpha-Phenylacetoacetate, |
methyl 3-oxo-2-phenylbutanoate |
23 |
4-AP |
4-AP |
4-piperidinamine, N-phenyl- |
24 |
1-boc-4-AP |
1-boc-4-AP |
4-(phenylamino)-1-piperidinecarboxylic acid, 1,1-dimethylethyl ester |
25 |
去甲芬太尼 |
Norfentanyl |
propanamide, N-phenyl-N-4-piperidinyl- |
列於本附表內物質的可能存在的鹽類。 |
|||
列於本附表內物質在其特定化學名稱下可能存在的異構體,但明確不列入本附表的異構體除外。 |
Tabela VI |
|||
N.º |
Denominação em chinês |
Denominação em português |
Denominação / Composição química |
1 |
丙酮 |
Acetona |
2-propanone |
2 |
鄰氨基苯甲酸 |
Ácido antranílico |
2-aminobenzoic acid |
3 |
乙醚 |
Éter etílico |
1,1’-oxybis[ethane] |
4 |
鹽酸 |
Ácido clorídrico |
hydrochloric acid |
5 |
甲基乙基酮 |
Metiletilcetona |
2-butanone |
6 |
哌啶 |
Piperidina |
piperidine |
7 |
硫酸 |
Ácido sulfúrico |
sulfuric acid |
8 |
甲苯 |
Tolueno |
benzene, methyl- |
列於本附表內物質的可能存在的鹽類,但鹽酸鹽及硫酸鹽除外。 |